NME1 and nasopharyngeal carcinoma: To confirm our microarray findings, we used immunohistochemistry (IHC), quantitative real-time PCR and western blot to determine the expression of NM23-H1, MMP-9 and VEGF165 in NPC tissues with and without intracranial invasion.